Currently, it can take anywhere from months to years to diagnose Alzheimer’s disease, but emerging blood tests for this condition could speed up this timeline, as well as having other significant benefits for patients. In this episode of Laborastories, Dr. Michael Hodsdon and Antonio Chambers of Eli Lilly Clinical Diagnostics Laboratory take an in-depth look at these promising tests and their nuances. They also discuss what labs should consider before offering these tests and when guiding clinicians on their appropriate usage.

This is a paid advertisement for Laborastories’ listeners brought to you by Eli Lilly Clinical Diagnostics Laboratory. The views expressed do not necessarily represent ADLM’s views, and their inclusion in this podcast is not an endorsement by Laborastories or ADLM.

With special guests:

Michael Hodsdon, MD, PhD, director of clinical chemistry, Eli Lilly Clinical Diagnostics Laboratory and Antonio Chambers, MS, MDT (AMT), director – technical, Eli Lilly Clinical Diagnostics Laboratory

Hosted by:

Eli Lilly Clinical Diagnostics Laboratory